Quest Diagnostics Market Cap 2010-2024 | DGX

Quest Diagnostics market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Quest Diagnostics market cap as of January 21, 2025 is $16.88B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.876B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.877B 0.00
DaVita (DVA) United States $13.632B 17.63
Encompass Health (EHC) United States $9.545B 22.50
Chemed (CHE) United States $8.349B 25.66
Elanco Animal Health (ELAN) United States $5.942B 14.14
Option Care Health (OPCH) United States $4.962B 23.52
RadNet (RDNT) United States $4.431B 98.13
LifeStance Health (LFST) United States $3.057B 0.00
Amedisys (AMED) United States $3.010B 21.42
Addus HomeCare (ADUS) United States $2.427B 28.48
Astrana Health (ASTH) United States $1.978B 27.05
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.943B 38.14
Aveanna Healthcare Holdings (AVAH) United States $0.899B 0.00
Atai Life Sciences (ATAI) Germany $0.245B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Daxor (DXR) United States $0.041B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00